|
1
|
Gomaa A, Khan S, Toledano M, Waked I and
Taylor-Robinson S: Hepatocellular carcinoma: epidemiology, risk
factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Montalto G, Cervello M, Giannitrapani L,
Dantona F, Terranova A and Castagnetta LA: Epidemiology, risk
factors, and natural history of hepatocellular carcinoma. Ann NY
Acad Sci. 963:13–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sherman M: Hepatocellular carcinoma:
epidemiology, risk factors, and screening. Semin Liver Dis.
25:143–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Parkin D, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
5
|
Yeh C, Chen T, Chang M, Hsu C and Yeh T:
Identification of NV-F virus DNA in hepatocellular carcinoma. J Med
Virol. 79:92–96. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levin B and Amos C: Therapy of
unresectable hepatocellular carcinoma. N Engl J Med. 332:1294–1296.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abou-Alfa G, Huitzil-Melendez F, O’Reilly
E and Saltz L: Current management of advanced hepatocellular
carcinoma. Gastrointest Cancer Res. 2:64–70. 2008.PubMed/NCBI
|
|
8
|
Boose G and Stopper H: Genotoxicity of
several clinically used topoisomerase II inhibitors. Toxicol Lett.
116:7–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Newman D, Cragg G and Snader K: The
influence of natural products upon drug discovery. Nat Prod Rep.
17:215–234. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams J and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cory S and Adams J: The Bcl-2 family:
regulators of the cellular life-of-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reed J: Mechanisms of apoptosis. Am J
Pathol. 157:1415–1430. 2000. View Article : Google Scholar
|
|
14
|
Borner C: Bcl-2 family members:
integrators of survival and death. Biochim Biophys Acta.
1644:71–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vaux D and Korsmeyer S: Cell death in
development. Cell. 96:245–254. 1999. View Article : Google Scholar
|
|
16
|
Gross A, McDonnell J and Korsmeyer S:
Bcl-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsu Y, Wolter K and Youle R: Cytosol to
membrane redistribution of members of the Bcl-2 family during
apoptosis. Proc Natl Acad Sci USA. 94:3668–3672. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wolter K, Hsu YT, Smith CL, Nechushtan A,
Xi XG and Youle RJ: Movement of Bax from the cytosol to
mitochondria. J Cell Biol. 139:1281–1292. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan C, Dlugosz PJ, Peng J, Zhang Z,
Lapolla SM, Johnson AE, Andrews DW and Lin J: Auto-activation of
the apoptosis protein Bax increases mitochondrial membrane
permeability and is inhibited by Bcl-2. J Biol Chem.
281:14764–14775. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Antonsson B, Montessuit S, Lauper S, Eskes
R and Martinou JC: Bax oligomerization is required for
channel-forming activity in liposomes and to trigger cytochrome c
release from mitochondria. Biochem J. 345:271–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jürgensmeier JM, Xie Z, Deveraux Q,
Ellerby L, Bredesen D and Reed JC: Bax directly induces release of
cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA.
95:4997–5002. 1998.PubMed/NCBI
|
|
22
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: a
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI and Jones DP: Prevention of apoptosis by Bcl-2:
release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomenius MJ, Wang NS, Reineks EZ, Wang Z
and Distelhorst CW: Bcl-2 on the endoplasmic reticulum regulates
Bax activity by binding to BH3-only proteins. J Biol Chem.
278:6243–6250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao G, Dai S and Chen R: Dictionary of
traditional Chinese medicine. Shanghai Scientific and Technical
Publishers. 2:2459–2460. 2006.
|
|
28
|
Cheueng S and Tai J: In vitro
studies of the dry fruit of Chinese fan palm Livistona
chinensis. Oncol Rep. 5:1331–1336. 2005.
|
|
29
|
Sartippour MR, Liu C and Shao ZM:
Livistona extract inhibits angiogenesis and cancer growth.
Oncol Rep. 6:1355–1357. 2001.
|
|
30
|
Wen CH, Rae MH and Lang MC: Selective
downregulation of EGF receptor and downstream MAPK pathway in human
cancer cell lines by active components partially purified from the
seeds of Livistona chinensis R. Brown. Cancer Lett.
248:137–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Li A, Dong XP and Xu XY: Screening
of anti-tumor parts from the seeds of Livistona chinensisand
its anti-angiogenesis effect. Zhong Yao Cai. 315:718–722. 2008.(In
Chinese).
|
|
32
|
Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan
Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa
willd inhibits colorectal cancer growth in vivo via inhibition of
STAT3 signaling pathway. Int J Mol Sci. 13:6117–6128. 2012.
View Article : Google Scholar
|
|
33
|
Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z
and Peng J: Scutellaria barbata D. don inhibits tumor
angiogenesis via suppression of hedgehog pathway in a mouse model
of colorectal cancer. Int J Mol Sci. 13:9419–9430. 2012. View Article : Google Scholar
|
|
34
|
Mantymaa P, Siitonen T, Guttorm T, Saily
M, Kinnula V, Savolainen ER and Koistinen P: Induction of
mitochondrial manganese superoxide dismutase confers resistance to
apoptosis in acute myeloblastic leukaemia cells exposed to
etoposide. Br J Haematol. 108:574–581. 2000. View Article : Google Scholar
|
|
35
|
Korper S, Nolte F, Rojewski MT, Thiel E
and Schrezenmeier H: The K+ channel openers diazoxide
and NS1619 induce depolarization of mitochondria and have
differential effects on cell Ca2+ in CD34+
cell line KG-1a. Exp Hematol. 31:815–823. 2003.
|
|
36
|
Kitada S, Pedersen IM, Schimmer AD and
Reed JC: Dysregulation of apoptosis genes in hematopoietic
malignancies. Oncogene. 21:3459–3474. 2002. View Article : Google Scholar : PubMed/NCBI
|
